Endpoints News
Arsalan Arif founded Endpoints News to realize a vision of an independent journalism company covering the most critical developments for leaders across the biopharma world. Arsalan has cultivated a global team of writers and media pros to serve that core mission, now with over 30 full-time staff and counting whose work is seen daily by decision-makers who are changing the world of medicine. Since founding the company in 2016 with editor John Carroll, Arsalan and his team have attracted more than 125,000 subscribers spanning executive and scientific leadership at the top 25 pharma companies and thousands of biotech startups across the globe. His journalism duties include editing Endpoints' Early Edition and contributing news reports on cybersecurity and technology. Before founding Endpoints, Arsalan was the publisher of FierceBiotech and launched FiercePharma at FierceMarkets in Washington, DC. After growing his career in the nation's capital, he returned to his native Kansas and now lives with his family in Lawrence. Born and raised in Wichita — the aviation capital of the world — Arsalan has been a private pilot for 21 years. His parents emigrated from India, built small businesses in Kansas, and credits them for his education and entrepreneurial drive.
This person is not in any teams
This person is not in any offices
Endpoints News
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. They produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. In this organization, the editors have complete authority to call the news as they see it.